Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rachel Ann Freedman, M.D.

Concepts (299)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms1202024208176.100 Why?
Receptor, erbB-224202224162.390 Why?
Chemotherapy, Adjuvant30202434742.210 Why?
Antineoplastic Agents, Hormonal10202115091.650 Why?
Breast Neoplasms, Male620232101.650 Why?
Mastectomy16202317931.390 Why?
Antineoplastic Combined Chemotherapy Protocols212022114931.350 Why?
SEER Program19202315081.270 Why?
Quinolines520227301.120 Why?
Survivors11202322910.980 Why?
Health Literacy220234140.960 Why?
Neoplasm Staging292023110070.890 Why?
Mastectomy, Segmental920249560.840 Why?
Medical Oncology7202122650.820 Why?
Health Knowledge, Attitudes, Practice5201939230.810 Why?
Mammography7202224770.800 Why?
Life Expectancy5202411840.760 Why?
Healthcare Disparities8202131580.750 Why?
Radiotherapy, Adjuvant7201617700.730 Why?
Female12620243801970.730 Why?
Self-Help Groups120211900.710 Why?
Aged7920241632530.700 Why?
Brain Neoplasms7202088600.660 Why?
Clinical Trials as Topic10202479080.650 Why?
Neoplasm Metastasis15202148410.630 Why?
Neoplasm Recurrence, Local13202492300.630 Why?
Axilla420225950.620 Why?
Receptors, Progesterone8202110970.560 Why?
Antineoplastic Agents112020136680.550 Why?
Receptors, Estrogen12202321860.550 Why?
Patient Selection5202142160.550 Why?
Humans13720247442200.530 Why?
Carcinoma, Intraductal, Noninfiltrating520249490.520 Why?
Aged, 80 and over352023577680.510 Why?
Age Factors172019183670.510 Why?
Carcinoma, Ductal, Breast6201911010.510 Why?
Interdisciplinary Communication120219500.510 Why?
Patient Participation2202114570.500 Why?
Hormone Replacement Therapy120207440.500 Why?
Breast10202319690.480 Why?
Estrogen Replacement Therapy1202012030.460 Why?
Neoplasms, Second Primary2202110610.440 Why?
Population Surveillance4201826160.430 Why?
Choice Behavior220168030.430 Why?
Middle Aged5620222133670.420 Why?
Epothilones12011440.400 Why?
Social Support1202121170.390 Why?
Withholding Treatment120155990.390 Why?
Paclitaxel5202217070.380 Why?
Geriatrics320203960.380 Why?
Neoplasms, Hormone-Dependent120134140.370 Why?
Benzothiazoles120112480.370 Why?
Prognosis162023290500.360 Why?
Health Services Accessibility3201951380.350 Why?
Geriatric Assessment2202313720.340 Why?
United States292023698670.340 Why?
Lymph Nodes2201734690.330 Why?
Neoplasms72022216720.320 Why?
Carboplatin220228000.320 Why?
Aminopyridines220225420.310 Why?
Health Education1201510550.310 Why?
Registries11202380900.310 Why?
Combined Modality Therapy9202486280.310 Why?
Patient Preference120158870.310 Why?
Adult4220232140350.310 Why?
Medical History Taking120117830.300 Why?
Tonsillar Neoplasms12007510.290 Why?
Referral and Consultation5202335280.290 Why?
Insurance, Health4201724940.290 Why?
Disease-Free Survival7202168930.280 Why?
Benzimidazoles220228510.280 Why?
Myelodysplastic Syndromes1201613520.280 Why?
Mammaplasty2201712040.280 Why?
Paget's Disease, Mammary22015190.270 Why?
Socioeconomic Factors4202077840.270 Why?
Mass Screening2202152520.260 Why?
Kaplan-Meier Estimate8202165350.260 Why?
Genetic Testing1201834430.260 Why?
Enoxaparin120083770.260 Why?
Postmenopause3202424610.250 Why?
Hospitals2201639520.250 Why?
Tamoxifen420249810.240 Why?
Insurance Coverage3201519010.240 Why?
Postpartum Hemorrhage120082580.240 Why?
Protein Kinase Inhibitors2202155290.240 Why?
Neoadjuvant Therapy3201927260.240 Why?
Survival Rate52019127810.240 Why?
Carcinoma, Lobular220194840.230 Why?
Drug Administration Schedule4201949290.230 Why?
Peripheral Nervous System Diseases220197000.230 Why?
Cyclophosphamide4202222360.230 Why?
Furans220211940.230 Why?
Ketones220211880.230 Why?
Follow-Up Studies92020390450.220 Why?
Cohort Studies132021405590.220 Why?
Medicare10202365660.210 Why?
Acupuncture, Ear12022130.210 Why?
Sentinel Lymph Node Biopsy420227080.200 Why?
Palliative Care1201734900.200 Why?
California2201514020.190 Why?
Leukemia, Myeloid, Acute1201635230.190 Why?
Odds Ratio5201798490.180 Why?
Medical Records2201814130.170 Why?
Xanthones12019250.170 Why?
Patient Care320226400.170 Why?
Lymph Node Excision4201912560.170 Why?
Pilot Projects3202283210.170 Why?
Young Adult152021564360.170 Why?
Interinstitutional Relations120202400.170 Why?
Retrospective Studies192023774260.160 Why?
Obesity22018127420.160 Why?
Premenopause2201310330.160 Why?
Perforin120181680.160 Why?
Treatment Outcome122021631190.160 Why?
Receptors, Steroid120171550.150 Why?
Feasibility Studies3202250760.140 Why?
Nitriles220219520.140 Why?
Quality of Life62018128050.140 Why?
Medication Systems, Hospital120171580.140 Why?
Epidemiologic Factors12015360.140 Why?
Practice Guidelines as Topic4202072810.140 Why?
Logistic Models42017134090.140 Why?
Cognition1201367650.130 Why?
Interferons120197060.130 Why?
Early Detection of Cancer3202230860.130 Why?
Acupuncture Therapy120194640.130 Why?
Tissue Distribution1201923350.130 Why?
Eukaryotic Initiation Factor-312015490.130 Why?
Clinical Trials, Phase III as Topic120198400.130 Why?
Proportional Hazards Models62023123550.130 Why?
Craniotomy120197290.130 Why?
Age Distribution2201829030.130 Why?
Lymphohistiocytosis, Hemophagocytic120182600.130 Why?
Randomized Controlled Trials as Topic3202099600.120 Why?
Anthracyclines120162880.120 Why?
Minority Health12015870.120 Why?
Adverse Drug Reaction Reporting Systems120174690.120 Why?
Patient Education as Topic2202122770.120 Why?
Gene Expression Profiling3202094380.120 Why?
Aftercare120208660.110 Why?
Patients120209000.110 Why?
Risk Factors102021722800.110 Why?
Eligibility Determination120164030.110 Why?
Radiotherapy2201715250.110 Why?
Consensus2202129580.110 Why?
Factor Analysis, Statistical120159770.110 Why?
Risk Assessment72023233370.110 Why?
Fatigue2201815310.110 Why?
Neoplasm Invasiveness3201936140.110 Why?
Decision Support Techniques2202119550.110 Why?
Hormones220218870.110 Why?
Anticoagulants1200845990.110 Why?
Lymphatic Metastasis2201729140.110 Why?
Demography1201716560.110 Why?
Menopause1202016260.110 Why?
Self Report3201835580.100 Why?
Physical Fitness120167330.100 Why?
Glioblastoma1200734810.100 Why?
Attitude to Health1202120530.100 Why?
Triazoles120179110.100 Why?
Administration, Oral1201939130.100 Why?
Insurance, Health, Reimbursement120153970.100 Why?
Confidence Intervals2201829700.100 Why?
Deglutition Disorders120176050.100 Why?
Resilience, Psychological120186750.100 Why?
Evidence-Based Practice120155000.100 Why?
Dose-Response Relationship, Drug22013109490.100 Why?
Health Insurance Portability and Accountability Act12011990.090 Why?
Women's Health1202020340.090 Why?
Connecticut120113660.090 Why?
Multivariate Analysis22015122440.090 Why?
Interferon-gamma1201932030.090 Why?
Minority Groups2201612230.090 Why?
Pyrazoles1202119730.090 Why?
Comorbidity22015103870.090 Why?
Time Factors62021400630.090 Why?
Estradiol1201720200.090 Why?
Male1520233500270.090 Why?
Incidence42021209450.090 Why?
Long-Term Care120136070.090 Why?
Radiation Injuries1201711780.090 Why?
Deoxycytidine120138250.080 Why?
Leukemia1201715080.080 Why?
Chi-Square Distribution1201535090.080 Why?
Lung Neoplasms42020130960.080 Why?
Fluorouracil1201316160.080 Why?
Risk2202096850.080 Why?
Adolescent72021857590.080 Why?
Prospective Studies72023532800.080 Why?
Health Care Surveys1201524530.080 Why?
Social Class2202119990.080 Why?
Guideline Adherence1201822660.080 Why?
Longitudinal Studies32019139900.070 Why?
Decision Making2202138880.070 Why?
Survival Analysis32016102500.070 Why?
Medicaid3202027360.070 Why?
Piperazines1201724910.070 Why?
Quinazolines1201313560.070 Why?
Anxiety1202142970.070 Why?
Databases, Factual3201777300.070 Why?
Infusions, Intravenous1201122720.070 Why?
Pyridines1201728220.070 Why?
Data Collection1201533400.060 Why?
Genomics1202157220.060 Why?
Angiogenesis Inhibitors1201520380.060 Why?
Workflow220228470.060 Why?
Pain1202049870.060 Why?
Blood-Brain Barrier1201110160.060 Why?
Quality Indicators, Health Care1201518310.060 Why?
Radiology1201820990.060 Why?
Educational Status1201225390.060 Why?
Exercise2201956150.060 Why?
Internet1201630630.060 Why?
Patient Satisfaction1201633950.060 Why?
Depression2202177670.060 Why?
Polymorphism, Single Nucleotide22020155250.050 Why?
Insurance Claim Review220177200.050 Why?
Guidelines as Topic2202014040.050 Why?
Diagnostic Imaging1201735080.050 Why?
Hospitalization22023102620.050 Why?
Prevalence22017152260.050 Why?
Mitosis1200712080.050 Why?
National Cancer Institute (U.S.)120222880.050 Why?
Pandemics1202183870.050 Why?
Doxorubicin2201722200.050 Why?
Aging2201986610.050 Why?
Antidepressive Agents1201228390.050 Why?
Neuropsychological Tests1201369910.050 Why?
Family1201131480.050 Why?
Evidence-Based Medicine1201136110.040 Why?
Clinical Competence1201546870.040 Why?
Cesarean Section1200813650.040 Why?
Nausea120226680.040 Why?
Academic Medical Centers2202027590.040 Why?
Disease Management2202024580.040 Why?
Genes, erbB-2120191620.040 Why?
Vomiting120226350.040 Why?
Frail Elderly120236930.040 Why?
Propensity Score2201617810.040 Why?
Heartburn12017680.040 Why?
Brain22020264130.030 Why?
Cancer Care Facilities120184020.030 Why?
Mediastinum120172670.030 Why?
Research Design2202259870.030 Why?
Case-Control Studies22016217520.030 Why?
Drug Prescriptions2201716370.030 Why?
Contract Services12015940.030 Why?
Multicenter Studies as Topic1202016770.030 Why?
Drug Therapy120174970.030 Why?
Medically Uninsured120208530.030 Why?
Hematopoiesis1202320690.030 Why?
Taxoids120176650.030 Why?
Amino Acid Substitution1201817920.030 Why?
Antigen Presentation1201912840.030 Why?
Office Visits120175980.030 Why?
Cell Line, Tumor22020166870.030 Why?
Observer Variation1201825930.030 Why?
Morbidity1201817690.030 Why?
Continuity of Patient Care1201910490.030 Why?
Exercise Therapy120199060.030 Why?
Proton Pump Inhibitors120175260.030 Why?
Mutation32023297840.030 Why?
Disease Susceptibility1201817820.020 Why?
Magnetic Resonance Imaging32020354230.020 Why?
Colorectal Neoplasms1201167730.020 Why?
Xenograft Model Antitumor Assays1201935570.020 Why?
Linear Models1202159530.020 Why?
Drug Labeling120122320.020 Why?
Qualitative Research1201926820.020 Why?
Reproducibility of Results22021199070.020 Why?
Preoperative Care1201922460.020 Why?
Tumor Burden1201519140.020 Why?
Vascular Endothelial Growth Factor A1202035060.020 Why?
Poverty1202126600.020 Why?
Aromatase Inhibitors120124910.020 Why?
Pyrimidines1202129400.020 Why?
Health Personnel1202232160.020 Why?
Drug Approval120157410.020 Why?
Prostatic Neoplasms12011110740.020 Why?
Child, Preschool22021409920.020 Why?
Drug Interactions1201214580.020 Why?
Lymphoma1201718730.020 Why?
Alleles1201869380.020 Why?
Body Composition1201624000.020 Why?
Boston1202093110.020 Why?
Tumor Microenvironment1201935840.020 Why?
Pregnancy12008291420.020 Why?
Immunosuppressive Agents1201841510.020 Why?
United States Food and Drug Administration1201215830.020 Why?
Cell Proliferation12019104800.010 Why?
Gene Expression Regulation, Neoplastic1201784260.010 Why?
Positron-Emission Tomography1201762740.010 Why?
Predictive Value of Tests12016150700.010 Why?
Infant12019351290.010 Why?
Signal Transduction12019234040.010 Why?
Tomography, X-Ray Computed12018201230.010 Why?
Mice12019811780.010 Why?
Child12019776790.010 Why?
Animals120191687880.000 Why?
Freedman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (299)
Explore
_
Co-Authors (99)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.